ENDRA Life Sciences Inc.

Good day, ladies and gentlemen, and welcome to the Indra Life Science Second Quarter 2021 Financial Results Conference Call. All lines have been placed on a listen-only mode, and the floor will be open for questions and comments following the presentation. At this time, it is my pleasure to turn the floor over to your host, Yvonne Briggs.

Ma'am, the floor is yours.

Thank you, Operator. This is Yvonne Briggs with LHA, Indra Life Science's investor relations firm. Good afternoon and welcome to Endra's second quarter 2021 business update and financial results conference call. Earlier today, Endra issued a press release on this topic. For those of you who don't have a copy, you can access it in the investor section of Endra's website at EndraInc.com. Before we begin, please note that today's discussion will include forward-looking statements. All statements other than statements of historical facts, including statements regarding the company's strategies, financial condition, operations, costs, plans, and objectives, as well as anticipated results of development and commercialization efforts, the timing of clinical studies, potential partnership opportunities, and expectations regarding receipt of required regulatory clearances and product launches are forward-looking statements. Except as otherwise required by federal securities laws, the company disclaims any obligation to update or revise any forward-looking statements. Please refer to the company's Form 10-K for the 2020 fiscal year filed with the SEC for more information about risks and uncertainties related to forward-looking statements. In terms of the structure of today's call, Francois Michelon, Chairman and Chief Executive Officer, will begin the prepared remarks followed by Renaud Malaberti, Endra's Chief Commercial Officer, and then Irina Pestrikova, Senior Director of Finance. Michael Thornton, Endra's Chief Technology Officer, will join us for the Q&A portion. With that said, I will now turn the call over to Francois Michelon. Francois?